STOCKSCOPE

Magmatic Resources (ASX: MAG) Advances Gold Discoveries at Weebo as Fortescue Partnership Strengthens Copper Exploration Potential

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:28 Oct 2026
Magmatic Resources (ASX: MAG) Advances Gold Discoveries at Weebo as Fortescue Partnership Strengthens Copper Exploration Potential

Magmatic Resources (ASX: MAG) is advancing a dual-commodity exploration strategy following encouraging gold drilling results at its Weebo Project in Western Australia and continued copper-gold exploration at Myall in New South Wales.

The company's September 2026 drilling campaign has strengthened its search for a substantial gold discovery, while its partnership with Fortescue provides externally funded exposure to large-scale copper exploration.

The central question is whether these programmes can establish economically significant mineral resources without placing excessive pressure on Magmatic's finances.

Key numbers

  • 270 square kilometres: Approximate area of the Weebo Gold Project in Western Australia's Yandal Greenstone Belt.
  • 6,591 metres: Phase 3 drilling completed at Weebo during May and June 2026.
  • 6m at 3.4g/t gold: Significant drilling intersection at the Scone Stone prospect.
  • $3.9 million: Expanded FY2026 exploration budget for the Fortescue-supported Myall Project.
  • $5.54 million: Cash reserves at 30 June 2026, alongside a $4.48 million annual net loss.

Weebo drilling brings Magmatic closer to defining a gold discovery

Magmatic's latest exploration activities have concentrated on identifying continuous gold-bearing structures across the Weebo Project.

On 25 September 2026, the company confirmed completion of follow-up reverse circulation drilling designed to investigate mineralisation identified during earlier campaigns.

The programme followed encouraging July results from several prospects, including Otto 2, Ockerburry 3 and Scone Stone.

At Otto 2, drilling returned 6m grading 1.96 grams per tonne gold, including 4m at 2.74g/t.

Ockerburry 3 delivered 8m at 1.52g/t gold, while Scone Stone produced 6m at 3.4g/t, including 1m at 13.9g/t.

These intersections demonstrate gold mineralisation across multiple targets, strengthening the geological rationale for additional drilling.

Importantly, aircore drilling also identified gold-bearing structures extending more than 700m at regional prospects.

However, individual intersections do not establish a commercially viable deposit.

Magmatic must demonstrate sufficient mineralisation continuity, thickness and grade before meaningful resource estimates or mine development economics can emerge.

Fortescue partnership provides a different route to growth

While Weebo represents Magmatic's principal gold exploration opportunity, Myall offers exposure to copper-gold discoveries in New South Wales' prospective East Lachlan region.

The project is being explored under a farm-in and joint venture agreement with Fortescue subsidiary FMG Resources.

Under the agreement, Fortescue can earn up to 75% ownership through exploration expenditure totalling $14 million, subject to the agreement's conditions.

This arrangement provides Magmatic with access to substantial exploration funding while limiting its direct financial exposure.

During FY2026, Myall's exploration budget increased from approximately $3.5 million to $3.9 million.

The programme included 16 diamond drill holes totalling 6,240.4m, targeting prospects including Interceptor, Barina and Calais.

Exploration has identified copper-gold mineralisation, although results remain preliminary.

The commercial attraction lies in potentially discovering a substantial porphyry system within an established mineral district.

Nevertheless, Fortescue's expenditure commitments do not constitute revenue from mining operations or guarantee a discovery.

Cash reserves improve, but exploration expenditure remains substantial

Magmatic's FY2026 results highlight the financial realities of advancing multiple exploration projects.

The company reported a net loss of $4.48 million, compared with approximately $2.17 million in FY2025.

Cash reserves increased to $5.54 million from $4.74 million, supported by additional equity funding.

Although this provides flexibility for ongoing drilling, the widening accounting loss demonstrates the cost of maintaining an active exploration portfolio.

Magmatic does not yet generate meaningful revenue from mineral production.

Consequently, earnings-based valuation multiples are unsuitable.

A more appropriate assessment depends on discovery potential, exploration expenditure, available funding and the probability of establishing economically recoverable resources.

Future capital raisings could dilute shareholders if exploration expenditure exceeds available cash.

What could establish Magmatic's next growth opportunity?

Magmatic's next important milestones involve assay results from September's Weebo drilling and additional exploration outcomes from Myall.

At Weebo, evidence of continuous, higher-grade mineralisation would strengthen the potential for resource-definition drilling.

At Myall, further copper-gold intersections could justify expanded exploration expenditure under the Fortescue partnership.

Both projects remain exposed to geological uncertainty, while future development would require substantial technical studies and funding.

Insight: Fortescue funding could make Magmatic's gold exploration more sustainable

What stands out to us is Magmatic's ability to pursue two exploration opportunities with different funding structures. Its $5.54 million cash balance supports company-funded drilling at Weebo, while Fortescue's potential $14 million expenditure commitment provides exposure to Myall without requiring Magmatic to fund the entire programme. This distinction could improve capital efficiency, although discovery risk remains considerable. We see the strongest opportunity in demonstrating economically meaningful mineralisation at Weebo, with the next decisive test being consistent gold grades and mineralised widths across follow-up drilling.

The verdict: Strong exploration potential still needs resource validation

Magmatic has strengthened its exploration portfolio through encouraging Weebo drilling and continued Fortescue-backed activity at Myall.

However, neither project has demonstrated commercial viability.

The opportunity depends on translating exploration results into defined mineral resources while maintaining financial discipline.

Upcoming Weebo assays and Myall drilling outcomes will be critical in determining whether Magmatic can progress towards a more substantial mineral development opportunity.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...